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Abstract
An IPTG-inducible mutant in the E6R gene of vaccinia virus was used to study the role of the E6
virion core protein in viral replication. In the absence of the inducer, the mutant exhibited a normal
pattern DNA replication, concatemer resolution and late gene expression, but it showed an inhibition
of virion structural protein processing it failed to produce infectious particles. Electron microscopic
analysis showed that in the absence of IPTG viral morphogenesis was arrested before IV formation:
crescents, aberrant or empty IV-like structures, and large aggregated virosomes were observed
throughout the cytoplasm. The addition of IPTG to release a twelve-hour block showed that virus
infectious particles could be formed in the absence of de novo DNA synthesis. Our observations
show that in the absence of E6 the association of viroplasm with viral membrane crescents is impaired.
Introduction
Poxviridae comprise a family of viruses that can infect both vertebrates and invertebrates.
These viruses are characterized by their large genomic DNA, cytoplasmic site of replication,
the encapsidation of an active transcription apparatus, and their complex morphology (Moss,
2007). One of the great challenges in the study of the biology of poxviruses is to understand
the morphogenesis steps that culminate with the production of the infectious virus particle
(Condit et al., 2006). Electron microscopy studies using vaccinia virus (VACV) as a model
have contributed to an understanding of the temporal sequence of events that culminates with
the formation of the infectious virion. During the second hour of infection, a cytoplasmic region
appears that is depleted of cellular organelles and can be delimited by an ER derived membrane
(Dales and Siminovith, 1961; Dales, 1963; Tolonen et al., 2001). This domain, also known as
a factory, viral factory or DNA factory, is thought to be the site of viral DNA replication. The
first indication of virion formation is the appearance of crescent-shaped membrane structures
within the factories (Dales and Mosbach, 1968; Sodeik et al., 1993; Risco et al., 2002).
Apparently, the crescent structures grow in length, and shortly afterwards they become closed
circles (spheres in three dimensions) named immature virions (IV). During this transformation
step, IVs become filled with material, called viroplasm, that is uniform in density but
discernibly more electron dense than the surrounding factory. Some IV contain an electron
dense, DNA containing “nucleoid” substructure and thus are called immature virions with
nucleoid (IVN) (Dales, 1963; Ericsson et al., 1995). Mature virions (MV) appear after a
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profound transformation of the internal IVN structure to form a biconcave core flanked by
lateral bodies, a process that is dependent on proteolysis. During this process MV migrate away
from the factories (Katz and Moss, 1970; Ansarah-Sobrinho and Moss, 2004; Byrd and Hruby,
2006).
Although the VACV genome was sequenced almost two decades ago, functional analysis of
the poxvirus genome is not complete (Goebel et al., 1990; Condit et al., 2006; Moss, 2007).
Temperature sensitive (ts) mutants or inducible knockout viruses have been used to identify
genes implicated in the formation of crescents, assembly of IV and the maturation of IV to
MV. Inducible knockout and ts viruses often differ mechanistically. In inducible knockout
viruses the target gene product is absent under non-permissive whereas in ts mutants the target
gene product may be stably synthesized but nevertheless inactive. One might therefore predict
that ts and inducible knockout viruses could present two distinct phenotypes when grown under
non-permissive conditions. However, for most of the genes studied to date ts and inducible
alleles have resulted in a similar phenotypes or phenotypes with only subtle differences (Kane
and Shuman, 1993; Szajner et al., 2001a; Byrd et al., 2002; Szajner et al., 2003; Unger and
Traktman, 2004; Szajner et al., 2004a; Mercer and Traktman, 2005). In at least one case
however, specifically phenotypic analysis of the G7L gene, the phenotype of an inducible
knockout mutant was found to be significantly and provocatively different compared to a ts
mutant in the same gene (Mercer and Traktman, 2005). Thus, the comparison of viruses bearing
a ts mutation or an inducible allele may contribute to a fuller understanding of gene function.
The complete mapping of the Condit/Dales collection of VACV temperature sensitive mutants
to single gene resolution mapped three ts mutants to the E6R gene, a virion protein of unknown
function (Kato et al., 2008). E6 is conserved in all chordopoxviruses but it has no distinguishing
functional motifs and no homologs in non-poxvirus organisms. In the preceding article (Boyd
et al., 2010), we showed that a ts mutant in the E6R gene (Cts52) grown under non permissive
conditions exhibited normal patterns of gene expression, late protein processing and DNA
replication, and produced virions that were indistinguishable in their morphology and protein
composition from wt virus. However, purified Cts52 virions grown under non-permissive
conditions were non-infectious and failed to transcribe in vitro. Concurrently with the
characterization of Cts52, we constructed a mutant virus bearing an inducible E6R gene (vE6i)
by substituting the natural E6R promoter with a bacteriophage T7 promoter regulated by the
lac operator. We show here that in the presence of the inducer, IPTG, vE6i produced a normal
yield of infectious particles but formed smaller than wt plaques. In the absence of IPTG, vE6i
displayed a normal pattern of DNA replication and late gene expression, but the processing of
the virion proteins was impaired. Resolution of concatemeric viral DNA replication
intermediates in the inducible mutant was not affected in the absence of the inducer. Analyses
by transmission electron microscopy revealed that under non-permissive conditions
morphogenesis was arrested before IV formation, and crescents, aberrant or empty IV-like
structures, and dense unencapsidated viroplasm were observed in the cytoplasm. When the
inducer block was released at a late time post infection, numerous filled IVs and a few normal
MVs could be formed even when the DNA replication inhibitor cytosine arabinoside was added
simultaneously with IPTG. Our results suggest that in the absence of E6 the association of
viroplasm with viral membrane crescents is defective. In conjunction with studies using ts
mutants presented in the accompanying paper, these results suggest that the E6 protein
functions at multiple steps during vaccinia morphogenesis.
Results
Construction and characterization of vE6i
To better understand the role of E6R in VACV replication, we engineered a recombinant
VACV in which E6R expression was strictly controlled by a bacteriophage T7 promoter and
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the Escherichia coli lac operator and repressor. The parent virus for the construction was
vT7LacOI, a recombinant VACV which constitutively expresses the lac repressor and which
also expresses the bacteriophage T7 RNA polymerase under control of a VACV promoter and
the lac operator (Ward et al., 1995). The construction was made by substituting the promoter
region of the endogenous E6R gene with a T7 promoter-lac operator-EMC IRES cassette
coupled to a gpt-cassette regulated by the VACV early-late 7.5-promoter (Fig 1A).
Recombinant virus was selected for growth in the presence of mycophenolic acid and IPTG.
The presence of the insertion in the recombinant virus was confirmed by sequencing of the
E5R-E6R region, and inducer independent virus could be recovered when vE6i was rescued
with a PCR product that spanned the E5-E6 region (data not shown).
To determine the IPTG requirement for plaque formation, plaque assays were conducted in the
presence of varying concentrations of inducer and the quantification of the assays is shown in
Fig. 1B. Virus plaqued in the absence of IPTG contains a low concentration of inducer
independent virus, which we interpret as revertants, likely formed by mutational inactivation
of the lac repressor in vE6i. Addition of increasing amounts of IPTG to plaque assays reveals
inducer-dependent plaque formation with a maximum titer and plaque size achieved at IPTG
concentrations of 50 μM and higher. The apparent virus titer increased more than 10 fold by
addition of presence of 25μM of IPTG and nearly 1000 fold with higher concentration of the
inducer. At concentrations of 50μM of IPTG and above the apparent titers of vE6i are
equivalent but the virus formed small plaques regardless of IPTG concentration. All subsequent
experiments were carried in the presence of 50μM of IPTG.
To determine whether the small plaque phenotype of vE6i was an effect of the length of the
incubation period, BSC40 cells were infected with 100 pfu of either VACV-WR or vE6i virus
under permissive conditions and incubated from 5 to 7 days. As shown in Fig. 1C, although
plaques produced by both viruses increased in size with time, vE6i plaques were consistently
smaller than wt regardless of incubation time. The reasons for the small plaque phenotype of
vE6i in the presence of inducer are not clear. It may be a direct consequence of altered E6R
expression resulting from manipulation E6R transcriptional regualtion, or it could result from
collateral damage acquired during construction of the mutant. Importantly, Resch et al
(2009) have also constructed an E6R inducible virus which displays a normal plaque size in
the presence of inducer, however that virus was constructed differently from ours. As described
above, in our construction the endogenous E6R promoter was substituted with a T7-LacOi
promoter region while in the Resch et al virus the endogenous E6R gene was inactivated with
a GFP insertion and a new copy of E6R under the control of T7-LacOi promoter was inserted
in the A56R gene region. It is possible that the 5′ end modifications made to the E6R gene in
our construction affect E6 expression in time or amount in a fashion that results in small plaque
size during vE6i infection under permissive conditions. It is also possible that vE6i has
sustained some collateral damage resulting (for example) from the expression of the GPT gene
that in our construction was placed in opposite direction to the E5R gene, and could therefore
theoretically influence E5R expression. Finally, is also possible that in the Resch et al
(2009) construction the plaque size would also be small but that the inactivation A56 (HA)
permits cell fusion and the appearance of large plaques (Turner and Moyer, 2008), thus masking
a small plaque phenotype. Regardless, the fundamental features of our vE6i mutant are similar
to the Resch et al mutant, and in our experiments the vE6i + IPTG controls behave as wt viruses
in all respects measured aside from plaque size and slightly delayed protein processing.
To confirm the lack of E6 synthesis in vE6i infection in the absence of IPTG, BSC40 cells
were infected at a MOI of 10 and at varying times the cells were harvested, the proteins
separated by SDS-PAGE, transferred to a nitrocellulose membrane and E6 was identified by
western blot. In the presence of the inducer no difference in the expression of E6 was observed
between WR and vE6i viruses. E6 is first detected at 9 h post infection and the protein continues
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to accumulate during the infection. However, in the absence of IPTG there was no expression
of E6 in the vE6i infection (Fig 2A).
The E6R gene is expressed late during the VACV replicative cycle and its synthesis is inhibited
by cytosine arabinoside (Assarsson et al., 2008; Boyd et al., 2010). To verify that the temporal
expression of VACV genes was not altered in infections by the vE6i recombinant, the synthesis
of two other viral proteins were analyzed: A18, which is expressed both early and late during
infection (Simpson and Condit, 1994; Assarsson et al., 2008), and L4, which is expressed late
during infection as a 28 kDa precursor and processed to a 25 kDa mature form (Yang et al.,
1988). As shown in Fig. 2B, during both WR and vE6i infection A18 expression started at 3
h post- infection and the amount of protein increased as the infection proceeded, consistent
with the previously described constitutive expression pattern. L4 protein synthesis was also
normal in vE6i infections done in the presence of IPTG but processing was slightly delayed:
a band corresponding to the precursor L4 protein was initially detected at 9 h post infection
but the mature form appears later and the protein accumulated throughout the infection.
One step growth, DNA replication and protein synthesis on vE6i infected cells
To investigate the different aspects of vE6i replication, we compared with WR infections the
production of infectious virus, synthesis of DNA, and protein synthesis in vE6i-infected cells
in the absence or presence of inducer. For one-step growth analysis, BSC40 cells were infected
at a MOI of 10 with either WR or vE6i in the absence or presence of IPTG, and at different
times after infection cells were harvested and the amount of virus in each sample was measured
by plaque assay (Fig. 3A). No difference was observed in the total amount of infectious virus
formed in WR infection in the absence or presence of IPTG since 34 and 38 pfu/cell respectively
were produced after 24 h of infection. Similar results were observed in cells infected with vE6i
in the presence of IPTG since 50 pfu/cell was generated in the same period. In the absence of
the inducer, the amount of infectious virus formed in vE6i infection declined and after 24h of
infection and only 0.2 pfu/cell was recovered. This result confirms that E6 is essential for
VACV replication and that the vE6i mutation is suitably tight for further phenotypic
characterization.
We next investigated whether synthesis of viral DNA and proteins was altered in vE6i
infections done under non-permissive conditions. For measuring the accumulation of DNA,
BSC40 cells were infected in the absence or presence of the inducer and at varying times the
cells were harvested, the cell lysates were applied to a slot-blot membrane, hybridized to
a 32P-labeled vaccinia DNA probe, and quantified using a phosphor-imager. As shown in Fig.
3B, both WR and vE6i viruses were able to synthesize DNA to the same extent and with
identical kinetics, regardless of the presence or absence of IPTG. This result shows that the
inability of vE6i to form infectious virus is not related to the synthesis and accumulation of
DNA.
Next, we investigated whether in the absence of IPTG the pattern of viral gene expression and
protein processing was altered in vE6i-infected cells. Protein processing is an important step
in morphogenesis; inhibition of proteolysis arrests virus morphogenesis at a premature stage
and conversely, treatments that interrupt virus morphogenesis at the IV/IVN stage also inhibit
proteolysis (Condit et al., 2006). To analyze the synthesis and processing of viral proteins
BSC40 cells were infected in the absence or presence of IPTG and at varying times total protein
synthesis was evaluated by pulse labeling with 35S-methionine for 30 minutes. After the
metabolic labeling, the cells were harvested, the proteins were separated by SDS-PAGE and
the radioactively labeled proteins were visualized by autoradiography (Fig. 4A). In the pulse-
labeling experiment, a normal pattern of viral protein synthesis was observed in WR infected
cells in the absence or presence of IPTG. Soon after the infection, shut-off of host protein
synthesis began and early viral proteins were observed at 3 h post-infection. After 6 h of
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infection a new protein profile composed of late protein synthesis emerged and continued
throughout the experiment. In the pulse labeling experiment, vE6i-infected cells in the absence
or presence the inducer presented a pattern of protein synthesis that was indistinguishable from
WR. To examine the processing of viral proteins, infected cells were labeled with 35S-
methionine at 9 h post-infection for 30 minutes and the radioactive proteins were chased in the
presence of unlabeled methionine before analysis by SDS-PAGE and detection by
autoradiography (Fig. 4A). In the pulse-chase experiment, cells infected with WR virus
presented a typical profile of protein processing at 12 and 24 h post infection. The precursor
proteins p4a and p4b, with molecular weights of 102 kDa and 73 kDa respectively, present at
9 h post infection were cleaved to a smaller size with molecular weights of 62 kDa and 60 kDa
respectively. A 23-kDa peptide that is formed from the processing of p4a can also be observed.
A similar profile was observed in vE6i infected-cells in the presence of IPTG where the
precursor proteins were cleaved to the same sizes observed in the wt infection. A different
picture emerges when vE6i infection is done in the absence of the inducer since in this
experimental condition p4a and p4 were not processed to the smaller size. This observation
was confirmed by western blot. As shown in Fig. 4B, in cells infected with WR virus the
precursor proteins p4a, p4b and pL4 were processed into 4a, 4b and L4 proteins that accumulate
during the infection. Protein processing was observed in vE6i-infected cells the presence of
IPTG but appeared somewhat reduced in efficiency compared to the wt infection. In the absence
of the inducer in vE6i infections, precursor proteins accumulate during infection and the low
molecular weight products were not formed. A small amount of the processed proteins was
observed in vE6i-infected cells in the absence of IPTG. This likely results from input virions,
since it was observed at zero hpi and the quantity was constant during the course of infection.
Finally, in the absence of IPTG vE6i-infected cells were unable to synthesize E6, which
accumulates in WR infection or in vE6i-infected cells in the presence of the inducer. These
results suggest that the absence of E6 interferes directly or indirectly the processing of the
major core proteins.
No mature virions are formed in the absence of E6
As shown above, in the absence of E6R expression the proteolytic processing of VACV
proteins was inhibited. Defects in proteolysis of this sort are often diagnostic of a defect in
virion morphogenesis (Szajner et al., 2003; Unger and Traktman, 2004; Szajner et al., 2004a;
Mercer and Traktman, 2005; Byrd and Hruby, 2005; Condit et al., 2006). To determine whether
virus morphogenesis was compromised BSC40 cells were infected with vE6i in the absence
or presence of the inducer. At 24 or 48 h post infection, cells were harvested and prepared for
electron microscopic analysis (Fig. 5). In the presence of IPTG, normal looking IV and MV
were formed in the cell cytoplasm at 24 (A) and 48 (B) h post infection. A different picture
emerged when vE6i was grown in the absence of IPTG. After 24 (C-D) or 48 (E-F) h post
infection large aggregated virosomes (AV) were formed, and crescents and empty IV were
found in the cytoplasm. A few IV and IVN were also present. Structures that resemble a MV
could be found but they were devoid of the core and lateral bodies (Fig. 5F). These results
suggest that in the absence of E6 virions were not able to efficiently encapsidate viroplasm and
DNA.
Viral DNA processing is not inhibited in the absence of E6
During VACV genome replication, DNA concatemers are formed and resolved into monomers
before being encapsidated into mature virions (Moyer and Graves, 1981). This phenomenon
requires expression of late genes and complete morphogenesis does not occur if the viral
resolvase gene (A22R) is not active (Merchlinsky and Moss, 1989; Garcia and Moss, 2001).
In the absence of A22, both concatemer resolution and maturation beyond IVN formation are
blocked. The ability of vE6i to resolve DNA concatemers was analyzed by Southern blot as
described (Merchlinsky and Moss, 1989). DNA isolated from virus-infected cells was digested
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with BstEII, the fragments separated in a 0.8% agarose gel, transferred to a nylon membrane
and hybridized to a VACV DNA probe containing the genomic terminal sequences. The
digestion of mature monomeric DNA with BstEII results in a 1.3-kb terminal fragment, whereas
DNA in the concatemeric form yields a 2.6-kb junction fragment (Fig. 6 scheme on top). Our
results show that in wt-infected cells (WR-IPTG) viral concatemer junctions were completely
resolved since only the 1.3-kb fragment was observed (Fig .6). Cts53, a mutant in rpo147 (J6R)
which is defective in late protein synthesis and telomere resolution at non-permissive
temperature, was used as a control and as a marker for the 2.6-kb concatemer junction fragment
(Hooda-Dhingra et al., 1989; Merchlinsky and Moss, 1989). At the permissive temperature in
a Cts53 infection (Cts53-31), the 1.3-kb resolved fragment is formed while at non-permissive
temperature (Cts53-40) the 2.6-kb concatemer junction fragment accumulates, as expected. In
vE6i-infected cells, in the absence or presence of IPTG, only the 1.3-kb fragment is formed.
This result shows that E6 is not involved in the formation of a monomeric mature viral DNA
molecule.
Induction of E6 during a non-permissive infection restores the ability of vE6i to produce
infectious particles
As described above, in the absence of the inducer, vE6i was not able to process the virion core
proteins and virus morphogenesis was arrested at an early stage of virion assembly
characterized by formation of empty IVs and aggregated virosomes. We were interested to
know whether the accumulated structures were viable for continued morphogenesis or were
dead-end products of an aborted assembly process. Thus to determine whether mature virions
could be formed late in a non-permissive vE6i infection following IPTG induction of E6
expression, BSC40 cells were infected with vE6i in the absence of IPTG. Twelve hours later,
IPTG was added to the infected cells in the absence or presence 40 μg/ml of cytosine
arabinoside (CAR), an inhibitor of DNA synthesis. At 6, 12 and 24 h after the addition of the
drugs (18, 24 and 36 hpi) samples were removed and the viral titer was determined. In the
absence of the inducer, vE6i was not able to form infectious particles and the virus titer slightly
increased from 0.02 (12 h) to 0.07 (36 h) pfu/cell (Fig. 7). By contrast, as early as six hours
after the addition of IPTG, the virus titer increased from 0.02 to 0.16 pfu/cell and after 24 and
36 h, the virus titer increased to 1.37 and 3.2pfu/cell respectively. A similar result was observed
when CAR and IPTG were added to the infected cells simultaneously. Within 6 h after addition
of the drugs, the virus titer increased from 0.02 to 0.12 pfu/cell and after 24 and 36 h of
incubation the virus titer increased to 1.11 and 2.13pfu/cell.
The formation of virus was also followed by electron microscopy (Fig. 8 A-F). After 12 h of
vE6i infection in the absence of IPTG crescents, empty IV and aggregated virosomes were
found in the cytoplasm of infected cells (data not shown). When the infection in the absence
of IPTG was extended to 36 h, a similar picture was observed with morphogenesis was still
arrested so that crescents and empty IV accumulated in the cytoplasm (A-B). Furthermore,
“rough aggregated virosomes” (RAV) were observed that were not associated with any viral
membrane structures, either rigid crescents or flaccid membranes, as have been observed after
rifampicin treatment (Grimley et al., 1970). When the E6 expression block was released by the
addition of IPTG and the infection was extended for an additional 24 h (36 hpi), all the steps
in virus assembly could be identified and normal looking IV, dense IV and a few MV were
present throughout the cytoplasm (C-D). The rough aggregated virosomes apparently became
smoother (SAV) and were surrounded by crescents that were filled with viroplasm. A similar
picture was observed with vE6i-infected cells when the E6 block was released by addition of
IPTG in the presence of CAR and the infection extended for 24 h. As in the absence of CAR,
crescents filled with viroplasm surrounding smooth aggregated virosomes, and normal looking
IV, dense IV and a few MV were present throughout the cytoplasm. We note that while
induction of E6 synthesis late during infection results in appearance of numerous normal
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looking IV, the numbers of MV as measured by electron microscopy or plaque titration, while
significantly increased, are relatively few compared to a normal wt infection. Our results
suggest that upon the release of block of E6R gene and the synthesis of E6 protein the virus
was able to resume morphogenesis and efficiently package viroplasm into membranes, and
that a few of these new IV may morph further to form new infectious virions, even in the
absence of de novo DNA synthesis.
E6 protein is unstable in the absence of any one of the 7-protein complex proteins
VACV proteins F10, A30, G7, J1, D2, and D3 form a 7-protein complex (7PC) that is
responsible for the association of membrane crescent structures with viroplasm (Szajner et al.,
2004a). In the absence of any one of these proteins, morphogenesis is arrested at an early stage,
empty crescents and aggregated virosomes are formed, and the other six proteins associated
with the complex become unstable (Dyster and Niles, 1991; Szajner et al., 2001a; Szajner et
al., 2001b; Szajner et al., 2003; Szajner et al., 2004a; Szajner et al., 2004b; Szajner et al.,
2004c; Mercer and Traktman, 2005). Since a similar picture of virus morphogenesis was
observed with vE6i in the absence of the inducer, we decided to compare the fate of two proteins
from the 7PC during vE6i infection. BSC40 cells were infected with vE6i and the following
ts mutants from the 7PC: Dts46 (A30), Cts11 (G7), Cts5 (D3), Cts45 (J1), Cts54 (F10) and
Ets52 (D2). Cts16, a mutant from the viral protease I7, was included as a negative control.
Infected cells were incubated for 24 h under permissive conditions (31°C or + IPTG) or non-
permissive conditions (40°C, or −IPTG or + rifampicin). Infected cells were then harvested,
the proteins were separated by SDS-PAGE, transferred to a nitrocellulose membrane, and the
western blots were probed with antibodies to the G7, A30, A10 and E6 proteins (Fig. 9). In all
samples from cells infected with the mutants under permissive conditions (P), the 42 kDa
precursor protein G7 (pG7) was processed into a 15 kDa protein (G7), similar to the wt
infection. Under non-permissive conditions (N), the accumulation of pG7 was reduced in all
the 7PC mutants and no G7 was produced by proteolysis. A different result was obtained in
cells infected with the mutant viruses Cts16, vE6i or with wt virus in the presence of rifampicin.
Under these conditions, there was a slight increase on the accumulation of pG7 and the mature
G7 protein was not formed. A similar result was obtained when the expression of A30 and A10
(p4a) were analyzed. Under permissive conditions, the 7PC mutants were able to express the
proteins and p4a was processed into 4a. However, under non-permissive conditions, the
accumulation of A30 and the processing of A10 were severely repressed. In cells infected with
Cts16, vE6i or wt under non-permissive conditions the expression of A30 was not repressed
but there was a significant inhibition of the processing of the p4a protein. The fate of E6 protein
was also analyzed in cells infected under permissive and non-permissive conditions. In cells
infected with the 7PC-mutants at 40°C, we observed a decrease in the accumulation of E6 when
compared with virus grown at 31°C, suggesting that E6 was unstable. In Cts16 infected cells
at 40°C or in wt infection in the presence of rifampicin, the accumulation of E6 was reduced.
No E6 expression was observed in vE6i-infected cells in the absence of IPTG. (Note that E6
made in the Dts46 infection has a slower mobility compared to E6 made in other infections.
We believe this results from the fact that Dts 46 is derived from the IHD-W strain of VACV
while the other viruses were derived from the WR VACV strain. DNA sequencing (not shown)
demonstrates that IHD-W contains two E6R polymorphisms compared to the WR strain,
T102A and K124E, which could theoretically retard the migration of the IHD-W protein.)
Taken together, these results show that the behavior E6 is different from the proteins from
the7PC, suggesting that E6 has a role in virus morphogenesis that is distinct from the 7PC.
Discussion
Genetic analysis of poxvirus morphogenesis reveals four distinct stages of virion assembly: 1)
membrane crescent formation, 2) association of viroplasm with membrane crescents to form
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IV, 3) DNA packaging to form IVN and 4) morphogenesis of IVN to MV (Condit et al.,
2006). Phenotypically, mutants in any stage of virion morphogenesis show no apparent defects
in late virus protein synthesis, so that theoretically the full complement of structural proteins
and assembly enzymes (save the mutant protein) are present. Transition from stage 3, IVN, to
stage 4, MV, is accompanied by and in fact requires cleavage of major structural precursor
proteins, notably the major core proteins p4a and p4b, and several others. The results presented
here demonstrate that when the virion core protein E6 is absent from infection, vaccinia
morphogenesis is arrested at stage 2, IV formation via association of viroplasm with membrane
crescents. Specifically, in the absence of E6R gene expression, late viral proteins are
synthesized and viral DNA is replicated and processed normally, but precursor structural
proteins are not processed, normal IV, IVN and MV are rare or absent, and instead infected
cells accumulate two significant aberrant structures, empty IV and aggregated virosomes.
Empty IV consist of membrane crescents and spheres that are devoid of the normal complement
of intermediate density viroplasm, and aggregated virosomes appear as very large accretions
of material resembling the intermediate density viroplasm that is normally packaged into IV.
A similar result has been observed recently by Moss and co-workers with an independently
constructed inducible mutant in the E6R gene (Resch et al., 2009). The simplest interpretation
of these results is that the E6 protein is required for the normal association of viroplasm with
viral membranes.
Mutants in several other virion proteins yield a phenotype virtually identical to the vE6i
phenotype observed here. These include mutants in genes A15L, A30L, D2L, D3R, G7L and
J1R (Szajner et al., 2001a; Szajner et al., 2001b; Chiu and Chang, 2002; Szajner et al., 2003;
Szajner et al., 2004a; Szajner et al., 2004b; Mercer and Traktman, 2005; Chiu et al., 2005).
Interestingly, these six proteins form a complex, dubbed the “seven protein complex” (7PC),
along with the product of the F10R gene, a viral serine/threonine protein kinase (Szajner et al.,
2004a; Resch et al., 2005). In contrast to other proteins in the complex, mutation of the F10R
gene yields a very early morphogenesis phenotype characterized by the complete absence of
crescents or other virion precursors, suggesting a pivotal early regulatory role for F10 in virion
morphogenesis (Traktman et al., 1995; Wang and Shuman, 1995; Szajner et al., 2004b).
Importantly, repression of synthesis of any of the proteins in the 7PC results in destabilization
of the remaining proteins in the complex (Szajner et al., 2004a). We therefore considered the
hypothesis that the vE6i phenotype was in fact a pleiotropic effect of destabilization of the 7PC
rather than a true reflection of E6 action. However, we found that two members of the 7PC,
A30 and pG7, remained stable during vE6i infections. Since repression of any one of the 7PC
complex proteins results in destabilization of the others, this result implies that the entire 7PC
complex remains stable during a vE6i infection. Interestingly however, we also found that the
E6 protein was destabilized during infection with 7PC mutants. One provocative interpretation
of this result is that in fact the E6 protein is the pivotal player in the 7PC/E6R mutant phenotype
and that the common phenotype of 7PC complex mutants reflects the destabilization of the E6
protein. In any case, our results show that E6R acts on the same pathway as the 7PC, promoting
the association of viroplasm with viral membrane crescents.
Structures resembling aggregated virosomes are frequently observed in mutant infections in
which early stages of assembly, specifically any step preceding formation of IVN, is disrupted.
For example mutants in the virion membrane proteins A14 or A17 or in gene A11R disrupt
normal membrane crescent formation and at the same time cause abnormal accumulation of
aggregated virosomes strikingly similar to the structures formed in a vE6i infection (Rodriguez
et al., 1995; Wolffe et al., 1996; Rodriguez et al., 1998; Resch et al., 2005). Likewise, as detailed
above, mutants in any of the 7PC complex proteins, like the vE6i mutants, result in
accumulation of aggregated virosomes. Lastly, mutants in several genes thought to interrupt
DNA packaging accumulate not only aggregated virosomes but also sometimes “crystalloid”
structures thought to represent deposits of unpackaged viral DNA (DeMasi et al., 2001; Garcia
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and Moss, 2001; Grubisha and Traktman, 2003; Unger and Traktman, 2004). Traktman et al.
(2000) have demonstrated that the aggregated virosomes that accumulate when membrane
crescent formation is prevented by repression of synthesis of the A14 viral membrane protein
contain concentrations of two DNA binding proteins, L4 and F17, that are normally found in
both IV and MV. These studies together suggest that the initial steps in vaccinia assembly can
be segregated into three subassembly processes: membrane crescent formation, assembly of
viroplasm, and DNA packaging. Under normal conditions these processes are coordinated,
however interruption of any one process may cause abnormal accumulation of other sub-
assemblies. Thus disruption of association of viroplasm with viral membrane crescents, as
observed in vE6i mutant infections, results in accumulation of both membrane crescent and
viroplasm sub-assemblies.
The intermediates that accumulate in vE6i infections could represent normal intermediates in
virus assembly or they could be dead-end products of an abortive assembly process. To
discriminate between these two hypotheses we conducted experiments to reverse the block in
E6 expression in the presence or absence of a DNA replication inhibitor. We found that even
in the absence of DNA replication, induction of E6 resulted in the resumption of
morphogenesis, efficient packaging of viroplasm into membranes to form IV, and the assembly
of some mature infectious particles. Following induction we observed by electron microscopy
viral membrane crescents associated with the large aggregated virosomes, apparently “biting
off” portions of viroplasm for packaging into virions. This implies that the viroplasm in
aggregated virosomes represents an accretion of normal, functional viroplasm competent for
packaging and subsequent morphogenesis. Likewise, it seems likely that the crescents and
empty IV that accumulate under non-permissive conditions during a vE6i infection are recycled
for use in assembly rather than disassembled and reassembled de novo. Preliminary confocal
microscopy studies (not shown) suggest that viral DNA is not concentrated in aggregated
virosomes but remains distributed normally throughout factories in a vE6i infection under non-
permissive conditions. Thus, repression of E6R gene function results in accumulation of
functionally competent intermediates in virus assembly, which may be used to resume
assembly upon induction of E6 synthesis. The resumption of assembly results in efficient IV
formation. MV formation is observed but is relatively inefficient. It remains to be determined
whether the apparent inefficiency of MV formation represents a downstream block to
morphogenesis or is a consequence of overall stress to the infection imposed by the
experimental protocol.
In the accompanying manuscript we described three temperature sensitive (ts) alleles of the
E6 gene which had identical phenotypes and which differed dramatically from vE6i (Boyd et
al., 2010). Under non-permissive conditions, association of viroplasm with membrane
crescents occurred normally during infection with all of the ts mutants, and MV were formed
which were indistinguishable from wt virus in appearance but which were nevertheless non-
infectious. Characterization of one of these ts alleles, Cts52, demonstrated that the non-
infectious particles formed under non-permissive conditions could bind and enter cells, but
that the virions were defective in virus core particle directed transcription in vitro. The
dramatically different phenotypes of the ts and inducible E6R mutants most likely relates to
the mechanism of conditional lethality in each case. Specifically, during infection with vE6i
under non-permissive conditions E6 protein is absent whereas in ts mutant infections E6 protein
is present but not functional. This suggests that the E6 protein functions in at least two steps
during virus morphogenesis, first for association of viroplasm with crescents and secondly for
some subtle aspect of MV formation that impacts either directly or indirectly on the virion
transcription reaction. In the absence of E6 protein as in vE6i infections, association of
membrane crescents with viroplasm cannot occur, however if the E6 polypeptide is present
but functionally compromised as in ts mutant infections, the membrane association with
viroplasm and appears normal, but some downstream event required for function of
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morphologically normal MV is defective. Numerous other examples exist of vaccinia genes
in which both ts and inducible alleles have been studied and in the majority of these cases the
phenotypes of the two types of mutation are similar or identical (Condit et al., 2006). However
in the case of gene G7L, which encodes one of the 7PC proteins, a ts allele caused a defect in
membrane crescent formation while repression of G7 synthesis resulted in a defect in
association of morphologically normal membrane crescents with viroplasm (Mercer and
Traktman, 2005). The authors in this case also interpreted this result to mean that G7 functioned
in multiple steps in virion morphogenesis. Thus comparison of ts and inducible alleles of a
given gene can reveal subtleties of gene function not gleaned from study of either mutant type
alone. The precise role of E6 in association of membrane crescents with viroplasm and the
formation of transcriptionally competent MV, and the potential relationship between the two
processes, remains to be determined.
Materials and Methods
Cell culture, virus, plaque assay, one-step growth
Viruses were grown in BSC-40 cells, an African green monkey cell line. The procedures for
cell culture, virus infection, purification, plaque assay and one-step growth have been described
previously (Condit and Motyczka, 1981; Condit et al., 1983; Kato et al., 2004). Wildtype
vaccinia virus strain WR was used as a control for the studies. For the construction of vE6i the
E6 ORF was PCR amplified and inserted into pVOTE.1 (Ward et al., 1995) to create pE6 with
E6 downstream from the T7 promoter and lac operator, and adjacent to a P7.5-gpt cassette.
The E5 flank was synthesized by PCR, and joined to a restriction fragment from pE6 consisting
of the P7.5-gpt cassette and the pT7-lacO-E6. The resulting linear DNA consisted of the pT7-
lacO promoter/operator and the P7.5-gpt cassette flanked by the E5 and E6 flanks, and was
recombined into vT7lacOI (Alexander et al., 1992) by selection for mycophenolic acid resistant
plaques in the presence of IPTG. The resulting construct was verified by sequencing to confirm
that unintended mutations had not been introduced into the E5 or E6 genes. Temperature
sensitive viruses Cts53 (J6R), Dts46 (A30R), Cts11 (G7L), Cts5 (D3R), Ct 45 (J1R), Cts 54
(F10L), Ets52 (D2L), Cts16 (I7L) were from our ts mutant collection and have been described
elsewhere (Hooda-Dhingra et al., 1989; Dyster and Niles, 1991; Traktman et al., 1995; Szajner
et al., 2001a; Byrd et al., 2002; Mercer and Traktman, 2005; Chiu et al., 2005).
Analyses of VV DNA slot-blot hybridization
BSC-40 cells were infected with VACV at moi of 10 pfu/cell and at different times post-
infection cell extracts were prepared and processed as described previously (Damaso et al.,
2002). The blots were analyzed on a Storm 860 phosphorimager (GE-Healthcare) using Image
Quant 5.1 software (Molecular Dynamics).
Metabolic labeling of viral proteins
Infected BSC-40 cells were incubated with 100 μCi/ ml of 35S-labeled amino acids mixture
(ProMix – GE Healthcare) in a methionine free media for 30 minutes. After this period, a cell
extract was prepared, proteins separated in a sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE), and analyzed by autoradiography as described before (Kato et
al., 2004).
Western blot analysis
BSC-40 cells were infected with wt VACV or vE6i in the absence or presence of 50μM of
IPTG. At varying times post-infection the cells were harvested and western blots were prepared
and analyzed as described previously (Kato et al., 2007). The E6 antibody has been described
previously and was used at a dilution of 1:1,000 (Boyd et al., 2010). The dilution and source
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of the other antibodies were: anti-A18 (1:20,000) monoclonal (Black et al., 1998); anti-L4
(1:100,000) rabbit serum was supplied by Dr. Dennis Hruby (Oregon State University); anti-
H4 (1:5,000) and anti-A3 (1:30,000) rabbit serum was supplied by Dr. Bernard Moss (NIAID);
anti-A10 (1:30,000) rabbit serum were supplied by Dr. Mariano Esteban (CNB-CSIC, Spain),
anti-G7 (1: 10,000) and anti-A30 (1:5,000) rabbit sera were supplied by Dr. Paula Traktman
(Wisconsin Medical School)
Electron microscopy
BSC40 cells were infected with either wt VACV or vE6i at a moi of 10 in the absence or
presence 50 μM of IPTG. Samples from 24 to 48 post-infection were fixed with 2%
glutaraldehyde in 0.1 M cacodylate buffer and post-fixed with 1% osmium tetroxide. After
dehydration, the samples were embedded in Embed 812 resin and visualized in a Hitachi
H-7000 electron microscope with assistance of the University of Florida ICBR Electron
Microscopy & Bioimaging Core Laboratory.
Telomere Resolution
The telomere resolution assay was done as described previously (Sekiguchi and Shuman,
1997). Briefly, monolayers of BSC40 cells infected with wt, Cts 53 or vE6i in the absence or
presence of 50 μM IPTG, at a moi of 10. The cells were harvested after 6, 12 and 24 hours post
infection, DNA was extracted, cleaved with BstE II (New England BioLabs), and fractionated
in a 1% agarose gel. Southern blots were prepared and probed with 32P-labeled pBD6
(Merchlinsky et al., 1988) as described (Sekiguchi and Shuman, 1997).
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Fig. 1.
Construction of vE6i inducible mutant.
A diagram of the modified regions in vE6i is shown in (A): the upper lines represent the J2R
and E5R - E6R regions that were modified. The white rectangles represent the unmodified E5R
and E6R ORF. The shaded rectangles represent the DNA insertions encoding for the
bacteriophage T7 RNA polymerase (T7RNApol) regulated by the late P11 promoter (P11) and
lac operator (lacO); E. coli lac repressor (lacI) regulated by the VACV p7.5 early/late promoter
(P7.5); E. coli xanthine-guanine phosphoribosyltransferase (E-gpt) regulated by p7.5. The E6R
natural promoter was substituted by a T7 promoter (PT7), lacO, and encephalomyocarditis
internal ribosomal entry site (IRES) regulatory sequence. The IPTG requirement for VACV
replication and the optimal concentration of the inducer was determined by titering vE6i in the
presence of increasing concentration of IPTG. After 72 hours, the cells were stain with crystal
violet and the viral plaques counted and graphed (B). To verify is the small plaque phenotype
was constant with time the plaque assay was incubated up 7 days before the cells were stained
with crystal violet (C).
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Fig. 2.
Expression and accumulation of E6.
To analyze the accumulation of E6 protein and the expression of VACV early and late genes,
BSC40 cells were infected with moi =10 with VACV-WR or vE6i virus in the absence or in
the presence of IPTG. At indicated times, cell extracts were prepared and the proteins were
separated on 11% SDS-PAGE and transferred to a nitrocellulose membrane. (A) The blot was
probed with E6 rabbit polyclonal antibody and developed by chemiluminescence. (B) The blots
were probed with E6 and L4 rabbit polyclonal antibodies and A18 mouse monoclonal antibody.
The dashed line indicates the separation of two different membranes. The lane (M) represents
the mock-infected cells.
Boyd et al. Page 16
Virology. Author manuscript; available in PMC 2011 April 10.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 3.
One-step growth and DNA replication.
BSC40 cells were infected at moi = 10 pfu/ml with VACV-WR or vE6i virus in the absence
or in the presence of IPTG. At indicated hours post infection samples were removed and the
virus yield was determined by plaque assay (A) and the amount of DNA measured by slot blot
hybridization (B). WR (−) IPTG (◆); WR (+) IPTG (■); vE6i (−) IPTG (▲);vE6i (+) IPTG
(●).
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Fig. 4.
Protein synthesis and proteolytic processing of viral proteins.
BSC40 cells were infected at moi = 10 pfu/cell and incubated in the presence or absence of
IPTG. (A) Cells were pulse-labeled (PL) with 35S methionine at various times post-infection,
indicated in hours at the top of each autoradiogram. The pulse-chase (PC) was performed by
incubating the cells with an excess of non-radioactive methionine, for the times indicated at
the top of each lane. Proteins were separated on an 11% SDS-PAGE, and gels were dried and
exposed to film. The virus and the incubation condition is indicated at the top of each gel.
Approximate molecular weights, in kDa, are indicated to the left of each autoradiograms. The
major viral core proteins p4a/4a, p4b/4b and 23 kDa are indicated on the right of the
autoradiograms. (B) Western blot analysis was performed on infected cell extracts prepared as
described above. The cells were harvested, a cell extract was prepared, and the proteins were
separated on an 11% SDS-PAGE, transferred to a nitrocellulose membrane, and blotted against
specific vaccinia virus proteins, as indicated on the right side of the figure.
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Fig. 5.
Electron micrograph of the vE6i infected cells.
BSC40 cells were infected with vE6i in the presence of IPTG (A, B) or in the absence of the
inducer (C – F). After 24 hpi (A – D) or 48 hpi (E – F) the cells were processed for microscopy
as described in Methods. IV= immature virions; MV= mature virions; WV= wrapped virions;
C= crescents; AV = aggregated virosome; N=nucleus.
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Fig. 6.
Telomere resolution.
A diagram showing relevant features of the viral genome concatemer junction and mature DNA
hairpin ends is shown in the top of the figure. Shaded areas represent direct repeats within the
viral termini. The arrows represent the site of cleavage of the BstE II restriction enzyme and
the double arrows represent the size of the fragment that is generated in both resolved and non-
resolved condition. The autoradiogram of the Southern blot is shown in the bottom part of the
figure. BSC40 cells were infected with WR or mutant virus at moi = 10 pfu/cell and incubated
in absence or presence of IPTG. Cts53 virus, used a positive control, was grown at 31 and 40°
C. DNA was extracted at various times post-infection, indicated in h at the top of each lane,
cleaved with BstE II, the fragments separated in an 0.8% agarose gel, blotted, and probed with
a 32P-labeled DNA containing concatemer junction sequences. The 2.6- and 1.3-kb bands,
indicated to the right of the autoradiogram, represent unresolved and resolved end fragments,
respectively. The slower migrating bands represent internal fragments hybridized to the probe
due to the presence of tandem repeat sequences.
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Fig. 7.
Release of the IPTG blockage.
A diagram on the top shows the scheme for the procedure. The vertical arrows represent the
hpi where samples were collected for plaque assay. The horizontal arrows represent the hours
of the blockage release. The result of the plaque assay is presented in the bottom part of the
figure. BSC40 cells were infected with vE6i at moi = 10 pfu/cell and incubated in absence
IPTG. At 12 hpi, IPTG or IPTG + CAR in fresh media were added to the cells. Cells that did
not receive the drugs were also supplemented with fresh media. At the indicated hpi, samples
were removed and the virus yield was measured by plaque titration.
Boyd et al. Page 21
Virology. Author manuscript; available in PMC 2011 April 10.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 8.
Electron micrograph after the IPTG blockage release.
BSC40 cells were infected with vE6i at moi = 10 pfu/cell and incubated in absence IPTG. At
12 hpi, fresh media with no drugs (A, B) or containing IPTG (C, D) or IPTG + CAR (E, F)
were added to the cells. After 24h of the blockage release (36 hpi), the cells were processed
for microscopy as described in Methods. EIV = empty immature virions; IV= immature virions;
MV= mature virions; WV= wrapped virions; C= crescents; RAV = rough aggregated virosome;
SAV = smooth aggregated virosome; N=nucleus.
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Fig. 9.
Stability of E6 in cells infected with mutants of the seven-protein complex.
BSC40 cells were infected with VACV mutants of the seven-protein complex (7PC) at moi =
10 pfu/cell and incubated 31°C (P) or 40°C (N) for 24 hours. After this period cell extracts
were prepared, proteins separated in a 11% SDS-PAGE, transferred to a nitrocellulose
membrane and blotted using rabbit antiserum against the VACV proteins G7, A30, A10 (p4a/
4a) and E6. A 15% SDS-PAGE was used for the analysis of the A30 protein. The mutant viruses
indicated in the lanes correspond to following genes: D46 (A30), C11 (G7), C05 (D3), C45
(J1), C54 (F10), E52 (D2), and C16 (I7). vE6i was incubated in the absence (−) or in the
presence (+) of IPTG. The arrows in the right of the figure indicate the VACV precursor (p)
or the protein. The numbers in the left of the figure represents the molecular weight markers
in kDa.
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